402 related articles for article (PubMed ID: 18304542)
21. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
[TBL] [Abstract][Full Text] [Related]
22. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
[TBL] [Abstract][Full Text] [Related]
24. Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns.
Vanky E; Carlsen SM
Fertil Steril; 2012 Feb; 97(2):509-15. PubMed ID: 22154766
[TBL] [Abstract][Full Text] [Related]
25. Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF.
Onalan G; Selam B; Baran Y; Cincik M; Onalan R; Gündüz U; Ural AU; Pabuccu R
Hum Reprod; 2005 Sep; 20(9):2391-5. PubMed ID: 15932917
[TBL] [Abstract][Full Text] [Related]
26. The use of metformin for women with PCOS undergoing IVF treatment.
Tang T; Glanville J; Orsi N; Barth JH; Balen AH
Hum Reprod; 2006 Jun; 21(6):1416-25. PubMed ID: 16501038
[TBL] [Abstract][Full Text] [Related]
27. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
Diamanti-Kandarakis E; Economou FN; Livadas S; Tantalaki E; Piperi C; Papavassiliou AG; Panidis D
Kidney Blood Press Res; 2009; 32(1):24-31. PubMed ID: 19212122
[TBL] [Abstract][Full Text] [Related]
28. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
[TBL] [Abstract][Full Text] [Related]
29. Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters.
Yildiz BO; Goodarzi MO; Guo X; Rotter JI; Azziz R
Fertil Steril; 2006 Dec; 86(6):1688-93. PubMed ID: 17074350
[TBL] [Abstract][Full Text] [Related]
30. Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
Mitkov M; Pehlivanov B; Terzieva D
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):209-13. PubMed ID: 15653205
[TBL] [Abstract][Full Text] [Related]
31. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Stanczyk FZ; Saxena T; Lobo RA
J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
[TBL] [Abstract][Full Text] [Related]
32. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.
An Y; Sun Z; Zhang Y; Liu B; Guan Y; Lu M
Clin Endocrinol (Oxf); 2014 Mar; 80(3):425-31. PubMed ID: 23869585
[TBL] [Abstract][Full Text] [Related]
33. Testosterone and dehydroepiandrosterone sulphate levels and IVF/ICSI results.
Hossein Rashidi B; Hormoz B; Shahrokh Tehraninejad E; Shariat M; Mahdavi A
Gynecol Endocrinol; 2009 Mar; 25(3):194-8. PubMed ID: 19347710
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of 4 treatments for woman polycystic ovarian syndrome with infertility].
Shi XB; Zhou LY; Fu SX; Chen JL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):359-62. PubMed ID: 16859124
[TBL] [Abstract][Full Text] [Related]
35. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.
Neveu N; Granger L; St-Michel P; Lavoie HB
Fertil Steril; 2007 Jan; 87(1):113-20. PubMed ID: 17081535
[TBL] [Abstract][Full Text] [Related]
37. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
[TBL] [Abstract][Full Text] [Related]
38. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
Carlsen SM; Kjøtrød S; Vanky E; Romundstad P
Acta Obstet Gynecol Scand; 2007; 86(2):145-50. PubMed ID: 17364275
[TBL] [Abstract][Full Text] [Related]
39. The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome.
Ertunc D; Tok EC; Aktas A; Erdal EM; Dilek S
Hum Reprod; 2005 May; 20(5):1207-12. PubMed ID: 15665022
[TBL] [Abstract][Full Text] [Related]
40. Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study.
Qublan HS; Yannakoula EK; Al-Qudah MA; El-Uri FI
Saudi Med J; 2007 Nov; 28(11):1694-9. PubMed ID: 17965792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
